ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B
2024 · Journal of Hepatology · 25 citations
https://doi.org/10.1016/j.jhep.2024.03.022
X
Xianhua Mao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
286
Citations
9
h-index
9
i10-index
Xianhua Mao is an academic researcher from Palo Alto University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Metabolism, Diabetes, and Cancer & Hepatitis B Virus Studies. The author has an h-index of 9, co-authored 19 publications.
ORCID: 0000-0003-4050-4759Papers by this author
worksApplication of a deep learning algorithm for the diagnosis of HCC
2024 · JHEP Reports · 14 citations
https://doi.org/10.1016/j.jhepr.2024.101219
536 ASSOCIATION BETWEEN GLYCEMIC CONTROL AND COLORECTAL ADENOMA AND CANCER RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A POPULATION-BASED COHORT STUDY
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)00769-8
1051 SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS ASSOCIATED WITH LOWER RISK OF HEPATOCELLULAR CARCINOMA AND HEPATIC DECOMPENSATION IN TYPE 2 DIABETES MELLITUS
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)04049-6
SAT-416 The impact of SGLT-2i and GLP-1RA on liver-related events in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis
2025 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(25)01679-4
FRI-101 Viral etiology of hepatocellular carcinoma as an independent determinant of survival for patients receiving tyrosine kinase inhibitor treatment
2025 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(25)01339-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat